Saturday 17 October 2026 Export OGN’s income statement to Excel — free account

Organon & Co.

OGN Healthcare Drug Manufacturers General

Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024. In the quarter to June 2026, revenue fell 2.26%, EPS fell 26.8%, free cash flow fell 83.0% and total debt fell 3.86%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

13.76 0.00 0.00%

Follow OGN

Alert me

Market cap: $3.6B
P/E: 17.4×
Fwd P/E: 5.2×
Dividend yield: 0.58%
F-score: 5/9
Altman Z: 1.09
Beneish M: −2.68
Dividend safety: 45/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	17.14	6.37	9.96	5.53	+8 more quarters Free account
P/S ratio Full definition →	0.58	0.25	0.30	0.44
P/FCF ratio Full definition →	7.66	2.79	4.48	4.45
P/Operating CF Full definition →	33.23	6.93	13.20	10.52
P/B ratio Full definition →	3.53	1.73	2.47	3.06
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	1.79	1.46	1.60	1.74
EV/EBITDA Full definition →	7.78	6.33	6.92	7.07
EV/Operating CF Full definition →	14.89	10.60	14.19	11.52
EV/FCF Full definition →	23.66	16.09	23.93	17.52
Quick Ratio Full definition →	1.00	1.00	0.80	0.80
Current Ratio Full definition →	1.95	1.97	1.82	1.75
Net Debt/EBITDA Full definition →	18.06	23.59	30.45	19.51
Debt/Assets Full definition →	64.90%	65.94%	67.18%	65.14%
Debt/Equity Full definition →	8.50	9.49	11.49	9.74
Asset Turnover Full definition →	0.46	0.47	0.48	0.48
Operating CF/Net income Full definition →	0.99	1.54	(0.69)	1.65
Capex/Depreciation Full definition →	(0.85)	(0.46)	(0.13)	(1.92)
Interest Coverage Full definition →	2.98	2.12	(0.75)	2.80
Research and Development Expense of Revenue Full definition →	5.78%	6.37%	6.04%	5.24%
Selling, General and Administrative Expense of Revenue Full definition →	27.86%	29.04%	28.73%	25.91%
Intangible Assets out of Total Assets Full definition →	0.40	0.40	0.41	0.44
Share Based Compensation of Revenue Full definition →	1.60%	1.30%	0.46%	1.50%
Graham Net Nets Full definition →	(1.99)	(4.59)	(4.17)	(2.86)
Graham Number Full definition →	8.25	8.56	6.85	12.30
Earnings Yield Full definition →	5.83%	15.69%	10.04%	18.07%
Free Cash Flow Yield Full definition →	13.05%	35.91%	22.30%	22.47%
Revenue per Share Full definition →	5.93	5.61	5.81	6.16
Operating CF per Share Full definition →	0.41	0.86	0.54	1.02
Capex per Share Full definition →	(0.29)	(0.14)	(0.17)	(0.44)
Free Cash Flow per Share Full definition →	0.12	0.72	0.37	0.57
Cash per Share Full definition →	4.31	4.29	2.21	2.58
Shareholders Equity per Share Full definition →	3.83	3.47	2.90	3.49
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	3.83	3.47	2.90	3.49
Free Cash Flow Full definition →	31.00	188.00	96.00	149.00
Working Capital Full definition →	2,495.00	2,432.00	1,962.00	2,021.00
Capital Expenditures Full definition →	(76.00)	(37.00)	(45.00)	(115.00)
Net Current Asset Value Full definition →	(7,061.00)	(7,161.00)	(7,763.00)	(7,946.00)
EV/EBIT Full definition →	13.32	10.91	12.05	9.09
Capex to Sales Full definition →	0.05	0.03	0.03	0.07
Price to Operating Income Full definition →	4.32	1.89	2.26	2.31
Other line items
Average Receivables Full definition →	1,488.00	1,420.50	1,344.50	1,584.50
Average Payables Full definition →	1,059.00	994.50	1,052.50	1,083.00
Average Inventory Full definition →	1,402.50	1,367.50	1,363.50	1,435.50
Average Assets Full definition →	13,339.00	13,076.00	12,984.00	13,152.00
Average Common Equity Full definition →	869.50	722.50	612.00	699.50

Fold the line items

Columns are period end dates

Stockrow Weekly